Cofactor’s cancer biomarker test outshines standard ICI predictive tests
Cofactor Genomics has showcased positive data highlighting that its clinical biomarker assay OncoPrism-HNSCC could guide doctors in choosing more effective…
Cofactor Genomics has showcased positive data highlighting that its clinical biomarker assay OncoPrism-HNSCC could guide doctors in choosing more effective…
Vidac Pharma has secured €600,000 ($645,651) in additional funding to support the clinical development of its two lead cancer candidates. …
Following Donald Trump’s re-election as the 47th President of the United States, the global healthcare community is beginning to examine…
Johnson & Johnson’s (J&J) Shockwave Medical unit has reported that its Javelin peripheral intravascular lithotripsy (IVL) catheter system successfully met…
Disc Medicine has announced a US Food and Drug Administration (FDA) agreement on the regulatory path for its investigational drug…
Teva Pharmaceuticals’ TEV-‘749 (olanzapine) has shown statistical improvement in schizophrenia symptoms in a Phase III trial. The Phase III SOLARIS…
As the role of technology and digital tools in clinical trials expands, industry leaders are grappling with how to balance…
Sunbird Bio has unveiled new data demonstrating that its diagnostic technology classified Parkinson’s disease-positive blood samples with 86% accuracy through…
A Phase II clinical trial evaluating Sinaptica Therapeutics’ neuromodulation device in Alzheimer’s disease has hit its primary and key secondary…
The World Health Organization’s (WHO) new framework aimed at strengthening clinical trial systems addresses a global issue of “major research…